Latest filing published 13 Nov 2023 for 昭衍新药, €15k.
Filing timeline
BuySaleInsider track record
姚大林: trading record in brief
姚大林, listed as board member, appears in our data through filings on 昭衍新药 shares, published by SSE / SZSE (CSRC). In total, 6 filings cover trades dated from 30 July 2021 to 13 November 2023.
The open-market record consists of 6 sales worth €274k, with no purchase. So far in 2023, the count stands at no purchases and 2 sales.
Most recently, on 13 November 2023, the filings show an open-market sale worth €15k in 昭衍新药. Publication is fast: at least half of the trades appear on SSE / SZSE (CSRC) on the same day. This delay matters because a trade only becomes useful information once it is public. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SSE / SZSE (CSRC). Past trades are no guide to future returns.
Companies and markets linked to 姚大林
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,000 shares5.4% of flowA股XSHGSSE:173000007087307460
- 3,000 shares4.2% of flowA股XSHGSSE:173000007075373760
- 2,000 shares12.1% of flowA股XSHGSSE:173000005648954080
- 1,000 shares6.2% of flowA股XSHGSSE:173000005599083140
- 1,000 shares5.8% of flowA股XSHGSSE:173000005576250560
- 7,400 shares66.3% of flowA股XSHGSSE:173000004616445660
6 of 6 declarations